Open AccessmiR-638 Serves as a Biomarker of 5-Fluorouracil Sensitivity to Neoadjuvant Chemotherapy in Breast Cancer
Author(s) -
Bin Wang,
Kun Wang,
Jian Yu,
Xiaomeng Hao,
Yu-Lu Liu,
Ai-Yan Xing
Publication year - 2022
Publication title -
journal of breast cancer/journal of breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 36
eISSN - 2092-9900
pISSN - 1738-6756
DOI - 10.4048/jbc.2022.25.e24
Subject(s) - apoptosis , flow cytometry , medicine , microrna , chemotherapy , cancer research , breast cancer , transfection , cell growth , downregulation and upregulation , biomarker , cancer , in vivo , oncology , biology , immunology , cell culture , gene , biochemistry , genetics , microbiology and biotechnology
Neoadjuvant chemotherapy (NAC) is widely used to treat breast cancer (BC). The prediction and evaluation of chemotherapy responses remains a significant challenge.